-
Mashup Score: 1Diversity in clinical research – where we are today, and can data and technology play a role to improve diversity - 1 year(s) ago
Sponsored by UBC & SymetryML The rare disease registry landscape consists of small, disjointed data sets stored across different national registries and localized consortia. These data silos, coupled with strict data privacy regulations, limit the collaboration that is needed by researchers to enhance analysis. In today’s webinar, we’ll show you how UBC has partnered with SymetryML and…
Source: BigMarker.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Diversity in clinical research – where we are today, and can data and technology play a role to improve diversity - 1 year(s) ago
Sponsored by UBC & SymetryML The rare disease registry landscape consists of small, disjointed data sets stored across different national registries and localized consortia. These data silos, coupled with strict data privacy regulations, limit the collaboration that is needed by researchers to enhance analysis. In today’s webinar, we’ll show you how UBC has partnered with SymetryML and…
Source: BigMarker.comCategories: Future of Medicine, Latest HeadlinesTweet-
On February 28th at 11:00 AM, hear leaders in the life sciences industry explore barriers and solutions to creating more equitable access to and participation in clinical trials. Register now: https://t.co/tbAW9Knjb3
-
-
Mashup Score: 1
Discussion of the nutritional management in clinical practice based on the forthcoming ISPAD 2022 guidelines on nutritional management of diabetes in children and experiences from 2 diverse centres and populations.
Source: BigMarker.comCategories: Latest Headlines, PediatricsTweet-
Don't miss #ISPAD's Educational #Webinar tomorrow! "Advances in Medical Nutrition Therapy in Type 1 Diabetes - From Theory to Practice", will take place on July 21, 2022 (1:30 pm CEST) . Open to all and free of charge! Sign up now! https://t.co/V2UifrmsMZ https://t.co/cLw4tB25Oh
-
-
Mashup Score: 1
Discussion of the nutritional management in clinical practice based on the forthcoming ISPAD 2022 guidelines on nutritional management of diabetes in children and experiences from 2 diverse centres and populations.
Source: BigMarker.comCategories: Latest Headlines, PediatricsTweet-
Don't miss #ISPAD's Educational #Webinar next week! "Advances in Medical Nutrition Therapy in Type 1 Diabetes - From Theory to Practice", will take place on July 21, 2022 (1:30 pm CEST) . Open to all and free of charge! Sign up now! https://t.co/V2UifrmsMZ https://t.co/VBvVkDlJ28
-
-
Mashup Score: 0
Discussion of the nutritional management in clinical practice based on the forthcoming ISPAD 2022 guidelines on nutritional management of diabetes in children and experiences from 2 diverse centres and populations.
Source: BigMarker.comCategories: Latest Headlines, PediatricsTweet-
2 weeks left until next #ISPAD's Educational #Webinar "Advances in Medical Nutrition Therapy in Type 1 Diabetes - From Theory to Practice" On July 21, 2022 (1:30 pm CEST) Open to all and free of charge! Sign up now! https://t.co/V2UifrmsMZ Read more: https://t.co/pXVkvx1gUA https://t.co/e75U9N5978
-
-
Mashup Score: 0
Discussion of the nutritional management in clinical practice based on the forthcoming ISPAD 2022 guidelines on nutritional management of diabetes in children and experiences from 2 diverse centres and populations.
Source: BigMarker.comCategories: Latest Headlines, PediatricsTweet-
#ISPAD's next Educational #Webinar on "Advances in Medical Nutrition Therapy in Type 1 Diabetes - From Theory to Practice" will take place on July 21, 2022 (1:30 pm CEST) . Open to all and free of charge! Sign up now! https://t.co/V2UifrmsMZ Read more: https://t.co/pXVkvx1gUA https://t.co/GjCN5sBZnE
-
-
Mashup Score: 1ICS Haryana Chapter - 2 year(s) ago
A Case of PSS related Progressive ILD managed with Recommended yet not Well-recognized Therapy
Source: BigMarker.comCategories: Hematologists1, Latest HeadlinesTweet-
Topic: ICS Haryana Chapter Time: May 28, 2022 07:30 PM India Meeting ID: 830 3809 5827 Passcode: 903828 PFB Link for Attendees: https://t.co/R0zvpV1liz @ScleroIndia @nihardesai7 @Prasshmehta @DrPMPGI @jyoti_archana https://t.co/iETSQ91sIi
-
-
Mashup Score: 0
Sponsored by Deloitte Racial and ethnic diversity among clinical trial participants is important to support science-driven strategies aimed at understanding the needs of those affected by the disease or condition being investigated. Join this panel discussion on how the biopharma industry can enhance clinical trial diversity. We’ll discuss opportunities to:
- Identify and…
Source: BigMarker.comCategories: Future of Medicine, Latest HeadlinesTweet-
How can biopharma companies increase the diversity of their clinical trial groups? On April 6, we sat down with leaders from Pfizer, Janssen and Takeda to discsus just that. View the disucssion: https://t.co/VIpm8Aygl8
- Identify and…
-
Mashup Score: 0
Sponsored by Deloitte Racial and ethnic diversity among clinical trial participants is important to support science-driven strategies aimed at understanding the needs of those affected by the disease or condition being investigated. Join this panel discussion on how the biopharma industry can enhance clinical trial diversity. We’ll discuss opportunities to:
- Identify and…
Source: BigMarker.comCategories: Future of Medicine, Latest HeadlinesTweet-
We recently sat down with Pfizer, Janssen and Takeda to explore strategies to improve clinical trial group diversity. View the disucssion here: https://t.co/cCeS3fCZw4
- Identify and…
-
Mashup Score: 1
Sponsored by Deloitte Racial and ethnic diversity among clinical trial participants is important to support science-driven strategies aimed at understanding the needs of those affected by the disease or condition being investigated. Join this panel discussion on how the biopharma industry can enhance clinical trial diversity. We’ll discuss opportunities to:
- Identify and…
Source: BigMarker.comCategories: Future of Medicine, Latest HeadlinesTweet-
In case you missed it! Watch our panel discussion around clinical trial group diversity with leaders from Pfizer, Janssen and Takeda. https://t.co/rsSjkKoENz
- Identify and…
It's not too late to register for our interactive panel discussion on February 28th at 11am EST. Learn how lack of diversity impacts clinical research today from industry leaders. #Diversity #Data https://t.co/o0rF8B0N7h